Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02807493 · ClinicalTrials.gov registry record · NA
Use of an Occlusal Support Device During the Second Stage of Labor
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 347
- Enrollment target
NCT02807493: Completed NA study, sponsored by University of Minnesota.
NCT02807493 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 347 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02807493, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
Study Summary
The primary objectives of this study are to determine if the use of an Occlusal Support Device (OSD)(Mouthguard) can reduce the duration and intensity of the second stage of labor, reduce the incidence of labor complications including Caesarian Sections and improve Apgar scores in newborns
Primary Outcome
Determine if an Occlusal Support Device (OSD) can reduce the duration of the second stage of labor
Interventions
- OTHER Control
- DEVICE Occlusal Support Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2017-04-01 |
| Est. Completion | 2021-03-26 |
| Phase | NA |
What the finished NCT02807493 record still lists
NCT02807493 is an interventional study that assigns participants to a tested intervention. The registered 347 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT02807493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02807493 about?
NCT02807493 is a clinical study titled "Use of an Occlusal Support Device During the Second Stage of Labor". The primary objectives of this study are to determine if the use of an Occlusal Support Device (OSD)(Mouthguard) can reduce the duration and intensity of the second stage of labor, reduce the incidence of labor complications including Caesarian Sections and improve Apgar scores in newborns
What is the current status of trial NCT02807493?
This trial is currently completed. It is a NA study. The enrollment target is 347 participants. The study started on 2017-04-01. Estimated completion is 2021-03-26.
What interventions are being tested in trial NCT02807493?
The interventions under investigation include: Control (OTHER), Occlusal Support Device (DEVICE).
Who is sponsoring clinical trial NCT02807493?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02807493's enrollment target sits among peer trials
347 302nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
- NCT04877522 · 347 participants · Phase 4
Asciminib Roll-over Study
- NCT05834660 · 347 participants · NA
SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
- NCT06963827 · 347 participants · Phase 3
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI